PL1789405T3 - Nowe enancjomerycznie czyste beta-agonisty, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych - Google Patents
Nowe enancjomerycznie czyste beta-agonisty, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczychInfo
- Publication number
- PL1789405T3 PL1789405T3 PL05737938T PL05737938T PL1789405T3 PL 1789405 T3 PL1789405 T3 PL 1789405T3 PL 05737938 T PL05737938 T PL 05737938T PL 05737938 T PL05737938 T PL 05737938T PL 1789405 T3 PL1789405 T3 PL 1789405T3
- Authority
- PL
- Poland
- Prior art keywords
- agonists
- drug
- production
- enantiomerically pure
- pure beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004024454A DE102004024454A1 (de) | 2004-05-14 | 2004-05-14 | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| PCT/EP2005/005079 WO2005111005A1 (de) | 2004-05-14 | 2005-05-11 | Neue enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| EP05737938.0A EP1789405B1 (de) | 2004-05-14 | 2005-05-11 | Neue enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1789405T3 true PL1789405T3 (pl) | 2013-12-31 |
Family
ID=34966720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05737938T PL1789405T3 (pl) | 2004-05-14 | 2005-05-11 | Nowe enancjomerycznie czyste beta-agonisty, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1789405B1 (pl) |
| JP (1) | JP2007537196A (pl) |
| KR (1) | KR101270447B1 (pl) |
| CN (4) | CN106995414A (pl) |
| AU (1) | AU2005243469B2 (pl) |
| BR (1) | BRPI0511102B1 (pl) |
| CA (1) | CA2562859C (pl) |
| CY (1) | CY1114702T1 (pl) |
| DE (1) | DE102004024454A1 (pl) |
| DK (1) | DK1789405T3 (pl) |
| ES (1) | ES2431118T3 (pl) |
| IL (1) | IL179217A (pl) |
| MX (1) | MXPA06013218A (pl) |
| NZ (1) | NZ551416A (pl) |
| PL (1) | PL1789405T3 (pl) |
| PT (1) | PT1789405E (pl) |
| RU (1) | RU2378262C2 (pl) |
| SI (1) | SI1789405T1 (pl) |
| WO (1) | WO2005111005A1 (pl) |
| ZA (1) | ZA200607152B (pl) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| DE102004024452A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation von Betaagonisten |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005007654A1 (de) | 2005-02-19 | 2006-08-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen |
| DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| US7994211B2 (en) | 2005-08-08 | 2011-08-09 | Argenta Discovery Limited | Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| MX2008001976A (es) * | 2005-08-15 | 2008-03-25 | Boehringer Ingelheim Int | Procedimiento para la preparacion de betamimeticos. |
| US7423146B2 (en) * | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
| CA2642239A1 (en) * | 2006-02-16 | 2007-08-23 | Boehringer Ingelheim International Gmbh | Drug combinations for the treatment of respiratory tract diseases |
| PE20080142A1 (es) * | 2006-03-15 | 2008-04-14 | Boehringer Ingelheim Int | Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| CN102838599A (zh) | 2006-05-04 | 2012-12-26 | 贝林格尔.英格海姆国际有限公司 | 多晶型 |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| UY30542A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
| PE20080610A1 (es) | 2006-08-22 | 2008-07-15 | Boehringer Ingelheim Int | Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos |
| MX2009005813A (es) * | 2007-01-25 | 2009-06-16 | Boehringer Ingelheim Int | Procedimiento para la preparacion de betamimeticos. |
| WO2009059893A1 (en) * | 2007-11-05 | 2009-05-14 | Boehringer Ingelheim International Gmbh | Crystalline hydrate of betamimetika and use as medicament thereof |
| EP2093219A1 (de) | 2008-02-22 | 2009-08-26 | Boehringer Ingelheim International Gmbh | Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel |
| PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| AU2009290911A1 (en) | 2008-09-10 | 2010-03-18 | Boehringer Ingelheim International Gmbh | Combination therapy for the treatment of diabetes and related conditions |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| AU2009331471B2 (en) | 2008-12-23 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Salt forms of organic compound |
| NZ594157A (en) | 2008-12-30 | 2013-07-26 | Pulmagen Therapeutics Inflammation Ltd | Sulfonamide compounds for the treatment of respiratory disorders |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| WO2010150014A1 (en) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
| GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
| GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
| KR102668834B1 (ko) | 2009-11-27 | 2024-05-24 | 베링거 인겔하임 인터내셔날 게엠베하 | 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료 |
| WO2011098746A1 (en) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone |
| GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| ES2935300T3 (es) | 2010-05-05 | 2023-03-03 | Boehringer Ingelheim Int | Combiterapia |
| KR20230051307A (ko) | 2010-06-24 | 2023-04-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 요법 |
| WO2012022796A2 (de) * | 2010-08-20 | 2012-02-23 | Boehringer Ingelheim International Gmbh | Neue kombinationen |
| US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
| EA030121B1 (ru) | 2011-07-15 | 2018-06-29 | Бёрингер Ингельхайм Интернациональ Гмбх | Замещенные хиназолины, их получение и их применение в фармацевтических композициях |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| WO2013171167A1 (en) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| EP2906218B1 (en) | 2012-10-09 | 2016-12-14 | Boehringer Ingelheim International GmbH | Beta-2-adrenoceptor agonist for the treatment of cough |
| CN102993116A (zh) * | 2012-12-04 | 2013-03-27 | 常州大学 | 一种苯并噁嗪类激动剂的制备方法 |
| MY176814A (en) * | 2013-08-08 | 2020-08-21 | Galapagos Nv | Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis |
| ES2950384T3 (es) | 2014-02-28 | 2023-10-09 | Boehringer Ingelheim Int | Uso médico de un inhibidor de DPP-4 |
| EP4233840A3 (en) | 2016-06-10 | 2023-10-18 | Boehringer Ingelheim International GmbH | Combinations of linagliptin and metformin |
| JP2019536812A (ja) | 2016-12-12 | 2019-12-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | オロダテロールとの同時投与による間質性肺疾患の処置方法に使用するためのニンテダニブ |
| PL3558954T3 (pl) | 2016-12-20 | 2022-01-31 | Inke, S.A. | Ulepszony sposób wytwarzania chlorowodorku r-6-hydroxy-8-[1-hydroksy-2-[2-(4-metoksyfenylo)-1,1-dimetyloetyloaminoetylo]-2h-1,4-benzoksazyno-3(4h)-onu |
| CN108997248B (zh) * | 2018-08-06 | 2023-08-01 | 上海方予健康医药科技有限公司 | 盐酸奥达特罗晶型b及其制备方法 |
| CN108822054B (zh) * | 2018-08-06 | 2021-06-22 | 上海方予健康医药科技有限公司 | 盐酸奥达特罗晶型c及其制备方法 |
| CN109096218B (zh) * | 2018-08-06 | 2020-10-27 | 上海方予健康医药科技有限公司 | 盐酸奥达特罗晶型a及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4656168A (en) * | 1980-12-23 | 1987-04-07 | Merck & Co., Inc. | (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation |
| DE3134590A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue benzo-heterocyclen |
| US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| DE3743265A1 (de) * | 1987-12-19 | 1989-06-29 | Boehringer Ingelheim Kg | Neue ammoniumverbindungen, ihre herstellung und verwendung |
| US5502078A (en) * | 1991-05-28 | 1996-03-26 | Zeneca Limited | Chemical compounds |
| JPH0912518A (ja) * | 1995-06-26 | 1997-01-14 | Kanegafuchi Chem Ind Co Ltd | ２−［１−（３´，４´−ジメトキシフェニル）−２−プロピルアミノ］−１−（３´−クロロフェニル）−エタノールの製造方法 |
| JPH11255743A (ja) * | 1998-03-06 | 1999-09-21 | Dainippon Pharmaceut Co Ltd | 光学活性のインドール誘導体の製造方法及びその製造中間体 |
| BR0114584A (pt) | 2000-10-12 | 2003-08-26 | Boehringer Ingelheim Pharma | Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento |
| AU2002231688A1 (en) * | 2000-12-21 | 2002-07-01 | Sanofi-Aventis Deutschland Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| HUP0400333A3 (en) | 2001-06-22 | 2012-10-29 | Boehringer Ingelheim Pharma | Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| WO2005110990A1 (de) * | 2004-05-13 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen |
-
2004
- 2004-05-14 DE DE102004024454A patent/DE102004024454A1/de not_active Withdrawn
-
2005
- 2005-05-11 BR BRPI0511102-1A patent/BRPI0511102B1/pt active IP Right Grant
- 2005-05-11 SI SI200531756T patent/SI1789405T1/sl unknown
- 2005-05-11 KR KR1020067026273A patent/KR101270447B1/ko active IP Right Grant
- 2005-05-11 AU AU2005243469A patent/AU2005243469B2/en active Active
- 2005-05-11 PT PT57379380T patent/PT1789405E/pt unknown
- 2005-05-11 DK DK05737938.0T patent/DK1789405T3/da active
- 2005-05-11 EP EP05737938.0A patent/EP1789405B1/de active Active
- 2005-05-11 NZ NZ551416A patent/NZ551416A/en unknown
- 2005-05-11 ES ES05737938T patent/ES2431118T3/es active Active
- 2005-05-11 RU RU2006144123/04A patent/RU2378262C2/ru active Protection Beyond IP Right Term
- 2005-05-11 CN CN201610884642.1A patent/CN106995414A/zh active Pending
- 2005-05-11 CA CA2562859A patent/CA2562859C/en active Active
- 2005-05-11 CN CN201610262144.3A patent/CN106146425A/zh active Pending
- 2005-05-11 CN CNA2005800154333A patent/CN101133039A/zh active Pending
- 2005-05-11 WO PCT/EP2005/005079 patent/WO2005111005A1/de active Application Filing
- 2005-05-11 CN CN201210347732.9A patent/CN102827097B/zh active Active
- 2005-05-11 PL PL05737938T patent/PL1789405T3/pl unknown
- 2005-05-11 JP JP2007512081A patent/JP2007537196A/ja active Pending
- 2005-05-11 MX MXPA06013218A patent/MXPA06013218A/es not_active Application Discontinuation
-
2006
- 2006-08-28 ZA ZA200607152A patent/ZA200607152B/xx unknown
- 2006-11-13 IL IL179217A patent/IL179217A/en active IP Right Grant
-
2013
- 2013-09-18 CY CY20131100810T patent/CY1114702T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1789405A1 (de) | 2007-05-30 |
| KR20070011602A (ko) | 2007-01-24 |
| IL179217A (en) | 2012-08-30 |
| EP1789405B1 (de) | 2013-07-17 |
| JP2007537196A (ja) | 2007-12-20 |
| PT1789405E (pt) | 2013-08-22 |
| IL179217A0 (en) | 2007-03-08 |
| CA2562859C (en) | 2012-05-08 |
| SI1789405T1 (sl) | 2013-09-30 |
| ZA200607152B (en) | 2008-04-30 |
| CN106146425A (zh) | 2016-11-23 |
| CY1114702T1 (el) | 2016-10-05 |
| AU2005243469B2 (en) | 2011-09-29 |
| MXPA06013218A (es) | 2007-02-08 |
| CA2562859A1 (en) | 2005-11-24 |
| DE102004024454A1 (de) | 2005-12-08 |
| AU2005243469A1 (en) | 2005-11-24 |
| CN102827097B (zh) | 2016-11-23 |
| BRPI0511102B1 (pt) | 2021-05-25 |
| ES2431118T3 (es) | 2013-11-25 |
| RU2378262C2 (ru) | 2010-01-10 |
| RU2006144123A (ru) | 2008-09-10 |
| DK1789405T3 (da) | 2013-10-14 |
| CN101133039A (zh) | 2008-02-27 |
| BRPI0511102A (pt) | 2007-11-27 |
| WO2005111005A1 (de) | 2005-11-24 |
| KR101270447B1 (ko) | 2013-06-04 |
| CN106995414A (zh) | 2017-08-01 |
| NZ551416A (en) | 2011-04-29 |
| CN102827097A (zh) | 2012-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200607152B (en) | Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug | |
| IL181012A0 (en) | Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments | |
| IL181007A0 (en) | Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament | |
| IL176913A0 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
| HK1088037A1 (en) | Methods for the production of insulin in plants | |
| PT1757582E (pt) | Arilalquilaminas e processo para a sua produção | |
| IL180874A0 (en) | Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments | |
| IL180897A0 (en) | Method of producing a composition, composition and its use | |
| PL378065A1 (pl) | Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych | |
| IL177087A0 (en) | Controlled-release pharmaceutical composition and method for producing the same | |
| ZA201001015B (en) | (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
| IL204556A0 (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
| IL179758A (en) | Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof and use of the same as medicaments | |
| EP1820538A4 (en) | COSMETICS AND MANUFACTURING METHOD THEREFOR | |
| IL179170A0 (en) | Novel substituted thiophenecarboxamides, their production and their use as medicaments | |
| IL180954A0 (en) | Nanoparticles and method for the production thereof | |
| IL228730A0 (en) | Pharmaceutical manufacturing process | |
| IL175245A0 (en) | Thiozolidinones, production and use thereof as medicaments | |
| ZA200703376B (en) | Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals | |
| EP1731139A4 (en) | PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR | |
| IL183395A0 (en) | Meta-substituted thiazolidinones, the production thereof and their use as medicaments | |
| EP1781773A4 (en) | MICROORGANISM AND METHOD FOR THE PRODUCTION OF PACLITAXEL USING THEREOF | |
| ZA200710146B (en) | New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents | |
| PT1763515E (pt) | Ácidos 4-trifluorometoxifenoxibenzeno-4¿-sulfónicos, processo para a sua preparação e utilização em medicamentos | |
| ZA200705782B (en) | Meta-substituted thiazolidinones, the production thereof and their use as medicaments |